Propel Bio Management »

Chinook Therapeutics Cvr shares owned by Propel Bio Management

Quarter-by-quarter ownership of Chinook Therapeutics Cvr shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Chinook Therapeutics Cvr

Tip: Access up to 7 years of quarterly data

All positions including Chinook Therapeutics Cvr held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chinook Therapeutics Cvr by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 79k 0.00

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Chinook Therapeutics Cvr

Rhumbline Advisers
Propel Bio Management
Ohio Pers

View all funds holding Chinook Therapeutics Cvr